What are the distinctions between ... [Clin J Oncol Nurs. 2003 Jan-Feb] - PubMed

Supplemental Content

Investigation of standard care versus sham Reiki placebo versus actual Reiki therapy to enhance comfort and well-being in a chemotherapy infusion center. [Oncol Nurs Forum. 2011]
Investigation of standard care versus sham Reiki placebo versus actual Reiki therapy to enhance comfort and well-being in a chemotherapy infusion center.
Catlin A, Taylor-Ford RL. Oncol Nurs Forum. 2011 May; 38(3):E212-20.
Review Reiki: a supportive therapy in nursing practice and self-care for nurses. [J N Y State Nurses Assoc. 2003]
Review Reiki: a supportive therapy in nursing practice and self-care for nurses.
Gallob R. J N Y State Nurses Assoc. 2003 Spring-Summer; 34(1):9-13.
Integrative care--Reiki. [Director. 2003]
Integrative care--Reiki.
Eliopoulos C. Director. 2003 Winter; 11(1):33-4.
Review Reiki therapy--a tool for wellness. [Imprint. 1999]
Review Reiki therapy--a tool for wellness.
Rivera C. Imprint. 1999 Feb-Mar; 46(2):31-3, 56.
Reconnecting to nursing through Reiki. [Creat Nurs. 2010]
Reconnecting to nursing through Reiki.
Natale GW. Creat Nurs. 2010; 16(4):171-6.

What are the distinctions between Reiki and therapeutic touch?
What are the distinctions between Reiki and therapeutic touch?
Clin J Oncol Nurs. 2003 Jan-Feb ;7(1):89-91.

PubMed
Reiki: a gift and a skill anyone can learn.
Reiki: a gift and a skill anyone can learn.
Beginnings. 2003 Jan-Feb ;23(1):12-3.

PubMed
Ovarian serous low malignant potential (borderline) tumor--does "micropapillary"...
Ovarian serous low malignant potential (borderline) tumor--does "micropapillary" matter?
Gynecol Oncol. 2010 Apr ;117(1):1-3.

PubMed
Replication of Yersinia pestis in interferon gamma-activated macrophages require...
Replication of Yersinia pestis in interferon gamma-activated macrophages requires ripA, a gene encoded in the pigmentation locus.
Proc Natl Acad Sci U S A. 2005 Sep 6 ;102(36):12909-14. Epub 2005 Aug 24 .

PubMed
Overcoming immunologic tolerance to melanoma: targeting CTLA-4 with ipilimumab (...
Overcoming immunologic tolerance to melanoma: targeting CTLA-4 with ipilimumab (MDX-010).
Oncologist. 2008 ;13 Suppl 4:16-25.

PubMed

Your browsing activity is empty.

Activity recording is turned off.